M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Lannett passes US FDA's approval for Oxycodone Hydrochloride Capsules 5 mg
Generic pharmaceutical company Lannett Company (NYSE:LCI) revealed on Monday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone Hydrochloride Capsules, 5 mg.
Oxycodone Hydrochloride Capsules, 5 mg is Lehigh...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives